We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$1.63B
AUM Growth
+$467M
Cap. Flow
+$322M
Cap. Flow %
19.7%
Top 10 Hldgs %
65.94%
Holding
135
New
10
Increased
33
Reduced
33
Closed
34

Top Buys

Rank Stock Value
1
KBR icon
KBR
KBR
+$25.3M
2
FIS icon
Fidelity National Information Services
FIS
+$23.2M
3
PRGO icon
Perrigo
PRGO
+$7.26M
4
ARRY icon
Array Technologies
ARRY
+$6.34M
5
ALIT icon
Alight
ALIT
+$6.1M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$25M
2
MASI
Masimo
MASI
+$19.9M
3
SPB icon
Spectrum Brands
SPB
+$19.1M
4
AMD icon
Advanced Micro Devices
AMD
+$17.6M
5
WIX icon
WIX.com
WIX
+$17.5M

Sector Composition

Rank Sector Weight
1 Technology 17.5%
2 Healthcare 14.87%
3 Communication Services 6.07%
4 Consumer Discretionary 5.21%
5 Consumer Staples 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEFT icon
76
Euronet Worldwide
EEFT
$3.15B
$1.77M 0.11%
17,448
-3,860
-18% -$329K
VTRS icon
77
Viatris
VTRS
$20.8B
$1.43M 0.09%
131,941
– –
ELV icon
78
Elevance Health
ELV
$83.7B
$1.38M 0.08%
2,919
-7,928
-73% -$3.67M
HAS icon
79
Hasbro
HAS
$13.6B
$1.32M 0.08%
25,792
– –
ACIW icon
80
ACI Worldwide
ACIW
$6.1B
$1.22M 0.07%
39,785
-172,167
-81% -$4.31M
HCP
81
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$1.2M 0.07%
+50,624
New +$1.1M
ALLK
82
DELISTED
Allakos
ALLK
$1.06M 0.07%
389,099
– –
TXMD icon
83
TherapeuticsMD
TXMD
$23.8M
$1.05M 0.06%
466,211
+10,823
+2% +$26.1K
MDRX
84
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.04M 0.06%
+99,507
New +$1.22M
NUVB icon
85
Nuvation Bio
NUVB
$2.33B
$747K 0.05%
494,506
– –
HUN icon
86
Huntsman Corp
HUN
$2B
$722K 0.04%
28,737
– –
NAUT icon
87
Nautilus Biotechnolgy
NAUT
$152M
$702K 0.04%
234,696
-30,207
-11% -$86.4K
BL icon
88
BlackLine
BL
$1.87B
$662K 0.04%
10,600
– –
LYRA
89
DELISTED
LYRA THERAPEUTICS INC
LYRA
$624K 0.04%
2,383
– –
LNSR icon
90
LENSAR
LNSR
$65.7M
$607K 0.04%
173,004
+56,991
+49% +$141K
GB
91
DELISTED
Global Blue Group Holding
GB
$408K 0.03%
86,175
+952
+1% +$4.78K
CGNT icon
92
Cognyte Software
CGNT
$657M
$403K 0.02%
62,741
-1,132
-2% -$5.66K
ORCL icon
93
Oracle
ORCL
$346B
$380K 0.02%
+3,600
New +$393K
CTMX icon
94
CytomX Therapeutics
CTMX
$701M
$305K 0.02%
196,583
– –
RCEL icon
95
Avita Medical
RCEL
$142M
$283K 0.02%
20,662
– –
GPRE icon
96
Green Plains
GPRE
$1.15B
$234K 0.01%
9,281
+2,616
+39% +$69.2K
WBD icon
97
Warner Bros
WBD
$64.2B
$175K 0.01%
15,352
-68,981
-82% -$745K
DOUG icon
98
Douglas Elliman
DOUG
$160M
$142K 0.01%
+48,204
New +$101K
LGTY
99
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$141K 0.01%
12,434
-179,548
-94% -$1.93M
GDEVW icon
100
GDEV Inc Warrant
GDEVW
$60.8K
$16.2K ﹤0.01%
257,393
-47,094
-15% -$5.81K
2 3
4
5 6

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Clearline Capital held 135 positions worth $1.63B, up 40% from $1.16B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Clearline Capital deployed $322M of net new capital in Q4 2023, opening 10 new positions and adding to 33 existing holdings. Its largest new stake was KBR: 458,198 shares worth $25.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Willis Towers Watson, an estimated $25M trimmed.

  • Clearline Capital's largest Q4 2023 buy was KBR: 458,198 shares worth $25.4M.
  • Clearline Capital added most to Fidelity National Information Services in Q4 2023, an estimated $23.2M increase.
  • Clearline Capital's biggest Q4 2023 reduction was Willis Towers Watson, cutting an estimated $25M.
  • Clearline Capital fully exited Spectrum Brands in Q4 2023, selling an estimated $19.1M.
  • Clearline Capital's ten largest holdings make up 66% of its $1.63B portfolio in Q4 2023.
  • Clearline Capital opened 10 new positions and closed 34 in Q4 2023.
  • Clearline Capital's portfolio value rose 40% quarter-over-quarter to $1.63B.

Based on Clearline Capital's 13F filing for Q4 2023, filed 14 Feb 2024.